Tianjin Pharmaceutical Da Ren Tang Group Corporation LimitedSSE: 600329

(600329)"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Announcement on Obtaining Drug Registration Certificate by a Branch

· Issued by Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited via Shanghai Stock Exchange

Filed with SSE · Stock code 600329 · · 3 pages · Chinese

Summary by 6ix AI

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited announced that its subsidiary has obtained a drug registration certificate for a new product, a sodium losoxone patch, from the National Medical Products Administration.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/600329tianjin-pharmaceutical-da-ren-tang-group-corporation-limitedannouncement-on-obtaining-drug-registration-certificate-by-a-branch

津药达仁堂集团股份有限公司（以下简称“公司”）所属分公司津药达仁堂集团股份有限公司新新制药厂于近日收到国家药品监督管理局核准签发的洛索洛芬钠贴剂《药品注册证书》，现将相关情况公告如下： 一、药品注册证书的主要内容 药品名称：洛索洛芬钠贴剂 剂型：贴剂 规格： （1）14cm×10cm，含洛索洛芬钠 100mg（按 C15H17NaO3计） （2）7cm×10cm，含洛索洛芬钠 50mg（按 C15H17NaO3计） 注册分类：化学药品 4 类 受理号：CYHS2501955、CYHS2501956 证书编号：2026S03661、2026S03662 上市许可持有人：津药达仁堂集团股份有限公司新新制药厂 生产企业：湖南派格兰药业有限公司 药品注册标准编号：YBH28462026 申请事项：药品注册（境内生产） 药品批准文号：国药准字 H20266172、国药准字 H20266173 审批结

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited on 6ix

Story so far

Earlier from Tianjin Pharmaceutical Da Ren Tang

All Tianjin Pharmaceutical Da Ren Tang news releases